Diagnostic Accuracy of Nonhyperemic Pressure Ratios Using a Pressure Sensing Microcatheter: The ACIST-FFR Study

ACIST-FFR Study Investigators

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1272-1275
Number of pages4
JournalJACC: Cardiovascular Interventions
Volume13
Issue number10
DOIs
StatePublished - May 25 2020

Bibliographical note

Funding Information:
Please note: The original work was supported by ACIST Medical Systems. Dr. Kobayashi has been a consultant for ACIST Medical Systems. Dr. Price has been a consultant for AstraZeneca, ACIST Medical, Boston Scientific, Medtronic, St. Jude Medical, and The Medicines Company; and receives speaker fees from AstraZeneca, Abbott Vascular, Medtronic, St. Jude Medical, Terumo, Chiesi USA, and The Medicines Company. Dr. Seto has received research support from ACIST Medical Systems; and has received speaking fees from ACIST Medical Systems and Volcano/Philips. Dr. Sarembock has been a consultant for Boston Scientific. Dr. Raveendran has been a consultant for Zurich Medical. Dr. Jeremias has been a consultant for Abbott Vascular, Philips/Volcano, ACIST Medical Systems, and Boston Scientific; and has served on the Speakers Bureau of Medtronic. Dr. Fearon has received research support from Abbott Vascular and Medtronic; has been a consultant for CathWorks and HeartFlow; and holds minor stock options with HeartFlow. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Funding Information:
Please note: The original work was supported by ACIST Medical Systems. Dr. Kobayashi has been a consultant for ACIST Medical Systems. Dr. Price has been a consultant for AstraZeneca, ACIST Medical, Boston Scientific, Medtronic, St. Jude Medical, and The Medicines Company; and receives speaker fees from AstraZeneca, Abbott Vascular, Medtronic, St. Jude Medical, Terumo, Chiesi USA, and The Medicines Company. Dr. Seto has received research support from ACIST Medical Systems; and has received speaking fees from ACIST Medical Systems and Volcano/Philips. Dr. Sarembock has been a consultant for Boston Scientific. Dr. Raveendran has been a consultant for Zurich Medical. Dr. Jeremias has been a consultant for Abbott Vascular, Philips/Volcano, ACIST Medical Systems, and Boston Scientific; and has served on the Speakers Bureau of Medtronic. Dr. Fearon has received research support from Abbott Vascular and Medtronic; has been a consultant for CathWorks and HeartFlow; and holds minor stock options with HeartFlow. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PubMed: MeSH publication types

  • Comparative Study
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

Cite this